IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Determination of MTHFR-G17793A gene polymorphism in Iraqi morbidly obese population and correlated that with apolipoprotein-A5 in increased risk of cardio vascular disease

Author: FATIMAH ABED, HANAAADDAI ALI, OMIDRANAEI SIADAT, SAREH ARJMAND, FATANEH FATEMI
Abstract: In this paper, because the methylenetetrahdrofolate reductase (MTHFR) association with many disease, we to evaluate the apolipoprotein-A5 (Apo-A5) levels and association of the polymorphism with morbidly obesity on risk of cardiovascular disease (CVD), a case-control study of 74 healthy morbidly obese and 76 healthy non-obese was conducted in Iraqi populationthat matched in gender and age. Apolipoprotein-A5, is main lipoprotein composing triglycerides rich lipoprotein and involving the risk of heart disease.Therefore Apo-A5 plays important role in regulation of lipids in the body. Although there are adequate traditional factors for cardiovascular risk but knowledge of genetic factor risk is still incomplete. Different biochemical parameters were measurement and polymorphism was genotyped by polymerase chain reaction (PCR-RFLP). The mean ± standard error (SE) and T test were estimate for clinical parameter and odds ratio (OR) with 95% confidence interval added to chi squire estimated for genotype to assess the strength of association between genetic and other factors. The results shows that morbidly obese have higher levels in blood pressure, cholesterol (Ch), triglyceride (TG), very low density lipoprotein (VLDL-C) and low density lipoprotein (LDL-C) than non-obese. In other hand shows not significant differences between two groups in value of high density lipoprotein (HDL-C) but show lower level in Apo-A5 in morbidly obese than non-obese groups. The study revealed that MTHFR-G1793A has not significant relation in three type normal homozygous ,heterozygous and rare homozygous with obesity.
Keyword: Apolipoprotein-A5, morbidly obese, MTHFR-G1793A, cardiovascular disease (CVD).
DOI: https://doi.org/10.31838/ijpr/2019.11.02.032
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
A BRIDGE BETWEEN PHARMACEUTICAL ANALYSIS & REGULATORY AFFAIRS

National Conference in collaboration with GTU on 06.07.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477